Keith R G Martin

Summary

Country: UK

Publications

  1. ncbi Gene therapy for optic nerve disease
    K R G Martin
    Eye Department, Addenbrookes Hospital, Cambridge, UK
    Eye (Lond) 18:1049-55. 2004
  2. ncbi Optic nerve dynein motor protein distribution changes with intraocular pressure elevation in a rat model of glaucoma
    Keith R G Martin
    Glaucoma Research Laboratory, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA
    Exp Eye Res 83:255-62. 2006
  3. ncbi Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model
    Keith R G Martin
    Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland 21287, USA
    Invest Ophthalmol Vis Sci 44:4357-65. 2003
  4. ncbi Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat
    Keith R G Martin
    Glaucoma Research Laboratory, Wilmer Eye Institute, Johns Hopkins University, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Invest Ophthalmol Vis Sci 43:2236-43. 2002
  5. ncbi Measurement of amino acid levels in the vitreous humor of rats after chronic intraocular pressure elevation or optic nerve transection
    Hana Levkovitch-Verbin
    Glaucoma Service, Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Glaucoma 11:396-405. 2002
  6. ncbi A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection
    Hana Levkovitch-Verbin
    Department of Ophthalmology, Wilmer Institute, Johns Hopkins Hospital, Baltimore, Maryland, USA
    Invest Ophthalmol Vis Sci 44:3388-93. 2003
  7. ncbi Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats
    Hana Levkovitch-Verbin
    Glaucoma Research Laboratory, Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Invest Ophthalmol Vis Sci 43:402-10. 2002
  8. ncbi Gene delivery to the eye using adeno-associated viral vectors
    Keith R G Martin
    Wilmer Eye Institute, Wilmer 122, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Methods 28:267-75. 2002
  9. ncbi The transcription factor c-jun is activated in retinal ganglion cells in experimental rat glaucoma
    Hana Levkovitch-Verbin
    Sam Rothberg Molecular Biology Lab, Goldschleger Eye Institute, Sheba Medical Center, Tel Aviv University, Tel Hashomer 52621, Israel
    Exp Eye Res 80:663-70. 2005

Detail Information

Publications9

  1. ncbi Gene therapy for optic nerve disease
    K R G Martin
    Eye Department, Addenbrookes Hospital, Cambridge, UK
    Eye (Lond) 18:1049-55. 2004
    ..There has been recent interest in the potential use of gene therapy techniques to treat ocular disease. In this article, we consider the optic nerve diseases that are potentially most amenable to gene therapy...
  2. ncbi Optic nerve dynein motor protein distribution changes with intraocular pressure elevation in a rat model of glaucoma
    Keith R G Martin
    Glaucoma Research Laboratory, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA
    Exp Eye Res 83:255-62. 2006
    ..The effect of IOP elevation on other motor proteins deserves further investigation in the future...
  3. ncbi Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma model
    Keith R G Martin
    Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland 21287, USA
    Invest Ophthalmol Vis Sci 44:4357-65. 2003
    ....
  4. ncbi Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat
    Keith R G Martin
    Glaucoma Research Laboratory, Wilmer Eye Institute, Johns Hopkins University, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Invest Ophthalmol Vis Sci 43:2236-43. 2002
    ..This study was conducted to investigate whether glutamate transporter changes occur with two models of optic nerve injury in the rat...
  5. ncbi Measurement of amino acid levels in the vitreous humor of rats after chronic intraocular pressure elevation or optic nerve transection
    Hana Levkovitch-Verbin
    Glaucoma Service, Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Glaucoma 11:396-405. 2002
    ..To investigate whether the levels of free amino acids and protein in the vitreous of rat eyes are altered with chronic intraocular pressure (IOP) elevation or after optic nerve transection...
  6. ncbi A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection
    Hana Levkovitch-Verbin
    Department of Ophthalmology, Wilmer Institute, Johns Hopkins Hospital, Baltimore, Maryland, USA
    Invest Ophthalmol Vis Sci 44:3388-93. 2003
    ..To use a rat model of optic nerve injury to differentiate primary and secondary retinal ganglion cell (RGC) injury...
  7. ncbi Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats
    Hana Levkovitch-Verbin
    Glaucoma Research Laboratory, Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Invest Ophthalmol Vis Sci 43:402-10. 2002
    ..To develop and characterize a model of pressure-induced optic neuropathy in rats...
  8. ncbi Gene delivery to the eye using adeno-associated viral vectors
    Keith R G Martin
    Wilmer Eye Institute, Wilmer 122, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287, USA
    Methods 28:267-75. 2002
    ..Our techniques facilitate the study of the pathogenesis of RGC diseases such as glaucoma and the development of novel new treatments based on gene therapy...
  9. ncbi The transcription factor c-jun is activated in retinal ganglion cells in experimental rat glaucoma
    Hana Levkovitch-Verbin
    Sam Rothberg Molecular Biology Lab, Goldschleger Eye Institute, Sheba Medical Center, Tel Aviv University, Tel Hashomer 52621, Israel
    Exp Eye Res 80:663-70. 2005
    ..C-jun is activated more gradually in glaucoma then after optic nerve transection...